Download
https://www.ndtvprofit.com/pti/astrazeneca-india-receives-dcgis-nod-to-market-drug-treating-breast-cancer?utm_source=telegram&utm_medium=referral&utm_campaign=socialshare
Lynparza is the first and only approved medicine targeting BRCA (Breast Cancer gene) mutations in early-stage breast cancer.
Share